✦ LIBER ✦

Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)

✍ Scribed by Sarah J. Lagedrost; Martin St. John Sutton; Meryl S. Cohen; Gary M. Satou; Beth D. Kaufman; Susan L. Perlman; Christian Rummey; Thomas Meier; David R. Lynch

Book ID: 116192353
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 442 KB
Volume: 161
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2010.10.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IDEBENONE IN FRIEDREICH ATAXIA CARDIOMYO

IDEBENONE IN FRIEDREICH ATAXIA CARDIOMYOPATHY: RESULTS FROM A 6 MONTHS PHASE III STUDY

✍ Sarah J. Lagedrost; Martin St. John Sutton; Sean R. Regner; Lauren A. Seyer; Kim 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Assessment of neurological efficacy of i

Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study

✍ Thomas Meier; Susan L. Perlman; Christian Rummey; Nicholas J. Coppard; David R. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 318 KB

Immunoadsorption in dilated cardiomyopat

Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study

✍ Alexander Staudt; Astrid Hummel; Jörg Ruppert; Marcus Dörr; Christiane Trimpert; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 191 KB

M.P.1.02 SNT-MC17/idebenone in the treat

M.P.1.02 SNT-MC17/idebenone in the treatment of Friedreich’s ataxia: Preliminary safety data from a 12-month European randomized, placebo-controlled study

✍ J.B. Schulz; T. Meier; G.L. Holder 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase III study of inhaled dry powder ma

Phase III study of inhaled dry powder mannitol (Bronchitol™) in cystic fibrosis – results from the 6 and 12 month open label phase

✍ D. Bilton; P. Robinson; P. Cooper; J. Kolbe; C.G. Gallagher; H. Fox; B. Charlton 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

77* Phase III Study [CF-302] of inhaled

77* Phase III Study [CF-302] of inhaled dry powder mannitol (Bronchitol(tm)) in cystic fibrosis – results from the 6 month open label phase

✍ M. Aitken; P.A. Flume; D.E. Geller; A. Lapey; J. Zuckerman; K. De Boeck; G. Bell 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB